Today's Top Stories


Hot Topics


Comment & Analysis »

GlobalData Healthcare

Artificial intelligence: the beginning of a new era in healthcare?

Artificial intelligence (AI) has already started to revolutionise healthcare, but this is only the beginning of a new...

Artificial intelligence: the beginning of a new era in healthcare?
GlobalData Healthcare

Pipeline biosimilar surge in emerging markets

Pipeline biosimilar surge in emerging markets
GlobalData Healthcare

Can DAA treatment increase the risk of HCC? Emerging data points towards ‘no’

Can DAA treatment increase the risk of HCC? Emerging data points towards ‘no’
GlobalData Healthcare

How your gut microbiome can interfere with cancer treatment and how to avoid it

How your gut microbiome can interfere with cancer treatment and how to avoid it
GlobalData Healthcare

Highlights from the 2017 ATS Conference: positive results for AstraZeneca’s Daliresp beyond reducing the risk of exacerbations

Highlights from the 2017 ATS Conference: positive results for AstraZeneca’s Daliresp beyond reducing the risk of exacerbations

Company Releases »

Flexible Drug Containers for Parenteral Drugs

Weibel CDS
Flexible Drug Containers for Parenteral Drugs

Rules for Investigating Good Manufacturing Practice (GMP) Deviations in Sterile Processing

NSF Health Sciences, Pharma Biotech
Rules for Investigating Good Manufacturing Practice (GMP) Deviations in Sterile Processing

Inspection and Analytical Services for the Pharmaceutical Industry

Quality Assurance Management (QAM) Inspection and Analytical Services for the Pharmaceutical Industry

Guide to Pharmaceutical Labelling Excellence

BLUE Software
Guide to Pharmaceutical Labelling Excellence

Pharmaceutical Insights »

Pharmaceutical Industry Reports »

The launch of long-acting therapies will drive the growth of the growth hormone meficiency Market

The launch of long-acting therapies will drive the growth of the growth hormone meficiency Market

Is diagnosed non-invasive ductal carcinoma in-situ breast cancer rarer in China?

Is diagnosed non-invasive ductal carcinoma in-situ breast cancer rarer in China?

Anticipated approval timeline of PARP inhibitors in HER2-negative breast cancer

Anticipated approval timeline of PARP inhibitors in HER2-negative breast cancer

Report: German pharmaceuticals market set to grow at CAGR of 4.9% by 2021

Report: German pharmaceuticals market set to grow at CAGR of 4.9% by 2021








cachename:HomePagecachekey:rd-1665407042_1729060782_rd-488908060_1460672566_ap1460672566_1729060782_-1100201212